Сипавибарт

Rec. INN (наименование, зарегистрированное ВОЗ)

2768288-97-5

immunoglobulin G1-lambda, anti-[Homo sapiens severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, receptor binding domain (RBD)], Homo sapiens monoclonal antibody;
gamma1 heavy chain Homo sapiens (1-455) [VH (Homo sapiens IGHV3-9*01 (94.9%) -(IGHD) -IGHJ1*01 (90.9%) L123>T (120), CDR-IMGT [8.8.18] (26-33.51-58.97-114)) (1-125) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14, IGHG1v39 CH2 F1.3, E1.2, S116, IGHG1v21 CH2 Y15.1, T16, E18 (CH1 R120 (222) (126-223), hinge 1-15 (224-238), CH2 L1.3>F (242), L1.2>E (243), M15.1>Y (260), S16>T (262), T18>E (264), P116>S (339) (239-348), CH3 E12 (364), M14 (366) (349-453), CHS (454-455)) (126-455)], (228-214')-disulfide with lambda light chain Homo sapiens (1'-215') [V- LAMBDA (Homo sapiens IGLV2-8*04 (94.8%) -IGLJ2*01 (100%), CDR-IMGT [9.3.9] (26-34.52-54.91-99)) (1'-109') -Homo sapiens IGLC2*01 (100%) (110'-215')]; dimer (234-234'':237-237'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1, glycoform alfa

Поделиться этой страницей